We are live on
!
Find out more
Regenxbio
RGNX
RGNX
89 hedge funds and large institutions have $704M invested in Regenxbio in 2017 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
332% more call options, than puts
Call options by funds: $2.12M | Put options by funds: $491K
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
112% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 17
57% more capital invested
Capital invested by funds: $448M → $704M (+$256M)
15% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 20
3% more funds holding
Funds holding: 86 → 89 (+3)
4.36% less ownership
Funds ownership: 73.51% → 69.15% (-4.4%)
Holders
89
Holders Change
+3
Holders Change %
+3.49%
% of All Funds
2.22%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
23
Increased
36
Reduced
17
Closed
20
Calls
$2.12M
Puts
$491K
Net Calls
+$1.63M
Net Calls Change
+$1.62M
Top Buyers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$9.38M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$6.49M |
| 3 |
RI
RTW Investments
New York
|
+$5.99M |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$5.06M |
| 5 |
BlackRock
New York
|
+$3.6M |
